Effective on June 30, 2019, Brendan Magrab tendered his resignation as a director of HedgePath Pharmaceuticals, Inc. Mr. Magrab's resignation was in connection with his previously announced transition off the company's Board of Directors to pursue other opportunities and was not based on any disagreement with the company on any matter relating to its operations, policies or practices.